Immune checkpoint inhibitors combined with tyrosine kinase inhibitors is the treatment option of previously treated advanced non-small cell lung cancer harboring EGFR or ALK genetic aberration

免疫检查点抑制剂联合酪氨酸激酶抑制剂是治疗既往接受过治疗且携带 EGFR 或 ALK 基因异常的晚期非小细胞肺癌的一种治疗选择。